Literature DB >> 11342006

Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose--potential implications for insulin resistance.

Z W Yu1, J Burén, S Enerbäck, E Nilsson, L Samuelsson, J W Eriksson.   

Abstract

UNLABELLED: It is well-established that high levels of cAMP or glucose can produce insulin resistance. The aim of this study was to characterize the interaction between these agents and insulin with respect to adipose tissue/muscle glucose transporter isoform (glucose transporter 4, GLUT4) gene regulation in cultured 3T3-F442A adipocytes and to further elucidate the GLUT4-related mechanisms in insulin resistance. Insulin (10(4) microU/ml) treatment for 16 h clearly increased GLUT4 mRNA level in cells cultured in medium containing 5.6 mM glucose but not in cells cultured in medium with high glucose (25 mM). 8-Bromo-cAMP (1 or 4 mM) or N(6)-monobutyryl cAMP, a hydrolyzable and a non-hydrolyzable cAMP analog, respectively, markedly decreased the GLUT4 mRNA level irrespective of glucose concentrations. In addition, these cAMP analogs also inhibited the upregulating effect of insulin on GLUT4 mRNA level. Interestingly, the tyrosine phosphatase inhibitor vanadate (1-50 microM) clearly increased GLUT4 mRNA level in a time- and concentration-dependent manner. Furthermore, cAMP-induced inhibition of the insulin effect was also prevented by vanadate. In parallel to the effects on GLUT4 gene expression, both insulin, vanadate and cAMP produced similar changes in cellular GLUT4 protein content and cAMP impaired the effect of insulin to stimulate (14)C-deoxyglucose uptake. In contrast, insulin, vanadate or cAMP did not alter insulin receptor (IR) mRNA or the cellular content of IR protein. IN
CONCLUSION: (1) Both insulin and vanadate elicit a stimulating effect on GLUT4 gene expression in 3T3-F442A cells, but a prerequisite is that the surrounding glucose concentration is low. (2) Cyclic AMP impairs the insulin effect on GLUT4 gene expression, but this is prevented by vanadate, probably by enhancing the tyrosine phosphorylation of signalling peptides and/or transcription factors. (3) IR gene and protein expression is not altered by insulin, vanadate or cAMP in this cell type. (4) The changes in GLUT4 gene expression produced by cAMP or vanadate are accompanied by similar alterations in GLUT4 protein expression and glucose uptake, suggesting a role of GLUT4 gene expression for the long-term regulation of cellular insulin action on glucose transport.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342006     DOI: 10.1016/s0925-4439(00)00097-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism.

Authors:  F Marampon; C Antinozzi; C Corinaldesi; G B Vannelli; E Sarchielli; S Migliaccio; L Di Luigi; A Lenzi; C Crescioli
Journal:  Endocrine       Date:  2017-08-07       Impact factor: 3.633

2.  Angiotensin II inhibits insulin-stimulated phosphorylation of eukaryotic initiation factor 4E-binding protein-1 in proximal tubular epithelial cells.

Authors:  D Senthil; J L Faulkner; G G Choudhury; H E Abboud; B S Kasinath
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

3.  Time-dependent alterations in mRNA, protein and microRNA during in vitro adipogenesis.

Authors:  Mahesh S Krishna; A Aneesh Kumar; K A Abdul Jaleel
Journal:  Mol Cell Biochem       Date:  2018-02-01       Impact factor: 3.396

4.  Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells.

Authors:  C Antinozzi; F Marampon; C Corinaldesi; E Vicini; P Sgrò; G B Vannelli; A Lenzi; C Crescioli; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-05-15       Impact factor: 4.256

5.  Opuntia cladode powders inhibit adipogenesis in 3 T3-F442A adipocytes and a high-fat-diet rat model by modifying metabolic parameters and favouring faecal fat excretion.

Authors:  Cécile Héliès-Toussaint; Edwin Fouché; Nathalie Naud; Florence Blas-Y-Estrada; Maria Del Socorro Santos-Diaz; Anne Nègre-Salvayre; Ana Paulina Barba de la Rosa; Françoise Guéraud
Journal:  BMC Complement Med Ther       Date:  2020-02-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.